Majlen Dilweg
Promovendus
- Naam
- M.A. Dilweg MSc
- Telefoon
- +31 71 527 4324
- m.a.dilweg@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-4455-3737
For more information look at the English website
Promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Medicinal Chemistry
- Veggel L. van, Mocking T.A.M., Sijben H.J., Liu R., Gorostiola González M., Dilweg M.A., Royakkers J., Li A., Kumar V., Dong Y.Y., Bullock A., Sauer D.B., Diliën H., Westen G.J.P. van, Schreiber R., Heitman L.H. & Vanmierlo T. (2024), Still in search for an EAAT activator: GT949 does not activate EAAT2, nor EAAT3 in impedance and radioligand uptake assays, ACS Chemical Neuroscience 15(7): 1424-1431.
- Wang X. Jespers W. Bongers B.J. Habben Jansen M.C.C. Stangenberger C.M. Dilweg M.A. Gutiérrez-de-Terán H. IJzerman A.P. Heitman L.H. Westen G.J.P. van (2020), Characterization of cancer-related somatic mutations in the adenosine A2B receptor, European Journal of Pharmacology 880: 173126.
- Yang X. Dilweg M.A. Osemwengie D. Burggraaff L. Es D. van der Heitman L.H. IJzerman A.P. (2020), Design and pharmacological profile of a novel covalent partial agonist for the adenosine A1 receptor, Biochemical Pharmacology 180: 114144.